SENZOLO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.202
AS - Asia 1.108
EU - Europa 890
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 9.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.190
CN - Cina 502
SG - Singapore 436
IT - Italia 222
FI - Finlandia 167
DE - Germania 132
SE - Svezia 125
VN - Vietnam 104
GB - Regno Unito 83
FR - Francia 76
IN - India 38
IE - Irlanda 18
RU - Federazione Russa 17
UA - Ucraina 16
NL - Olanda 11
CA - Canada 9
JP - Giappone 9
RO - Romania 6
HK - Hong Kong 5
TW - Taiwan 5
BE - Belgio 3
BR - Brasile 3
ES - Italia 3
GR - Grecia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
CH - Svizzera 2
ET - Etiopia 2
MX - Messico 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
MA - Marocco 1
PL - Polonia 1
PR - Porto Rico 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 9.213
Salva come PNG Salva come JPEG
Città #
Fairfield 1.208
Woodbridge 698
Chandler 598
Houston 560
Ashburn 528
Ann Arbor 495
Seattle 423
Cambridge 407
Singapore 354
Wilmington 341
Santa Clara 189
Boardman 181
San Diego 158
Princeton 132
Beijing 125
Medford 120
Dong Ket 104
Des Moines 101
Helsinki 95
Roxbury 69
Nanjing 61
Padova 60
Guangzhou 45
Jacksonville 42
Shenyang 27
London 24
Shanghai 20
Munich 18
New York 18
Dearborn 16
Pune 15
Washington 15
Hebei 14
Dublin 13
Jinan 13
Hefei 12
Milan 12
Ogden 11
Changsha 10
Rome 10
Tianjin 10
Kilburn 9
Los Angeles 9
Redwood City 9
Chicago 8
Cologno Monzese 8
Nanchang 8
Phoenix 8
Dallas 7
Esslingen am Neckar 7
Kunming 7
Vicenza 7
Zhengzhou 7
Chiswick 6
Fuzhou 6
Jiaxing 6
Borås 5
Kharkiv 5
Ningbo 5
Nürnberg 5
Paris 5
Rockville 5
Bologna 4
Dolo 4
Nonantola 4
Norwalk 4
Taipei 4
Tokyo 4
Toronto 4
Trieste 4
Venezia 4
Chengdu 3
Chongqing 3
Florence 3
Hangzhou 3
Hong Kong 3
Lozzo Atestino 3
São Paulo 3
Tappahannock 3
Tivoli 3
Acton 2
Addis Ababa 2
Ahmedabad 2
Amsterdam 2
Baku 2
Biassono 2
Brussels 2
Central 2
Fremont 2
Gazzo 2
Groningen 2
Gurgaon 2
Hounslow 2
Ichikawa 2
Indiana 2
Lappeenranta 2
Las Vegas 2
Miyaharachō 2
Modena 2
Moosburg 2
Totale 7.597
Salva come PNG Salva come JPEG
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 194
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 169
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 165
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 148
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy 146
18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation 136
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 125
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 122
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 120
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 119
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 117
Markers of acute rejection and graft acceptance in liver transplantation. 110
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 109
Non Adherence To Medical Prescriptions In Liver Transplantation: A Prospective Longitudinal Study 109
Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF 107
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis. 106
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 106
Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease 105
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 105
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 105
Obliterative portal venopathy without portal hypertension: An underestimated condition 101
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 100
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 99
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 99
Predictors of Response To Anticoagulant Therapy For the Treatment of Portal Vein Thrombosis (pvt) In Cirrhosis Patients 99
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 97
Neuropsychological alterations in hepatitis C infection: the role of inflammation. 95
Perioperative thrombotic complications in liver transplantation 95
Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis 94
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 94
Cyanoacrylate injection to treat recurrent bleeding from Dieulafoy's lesion. 93
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 91
Successful pregnancy in Alagille Syndrome. 90
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 90
Therapeutic approaches for portal biliopathy: A systematic review 89
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 88
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 88
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 86
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 86
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 86
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 84
Effect of Low Molecular Weight Heparin (lmwh) On Thrombin Generation In Cirrhotic Patients At Different Stages of Liver Disease 83
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 83
Liver transplantation for viral hepatitis in 2015 83
Recurrent facial dyskinesias due to extrapontine myelinolysis 82
New insights into the coagulopathy of liver disease and liver transplantation 81
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma 81
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis 81
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 81
Hepatitis C virus and liver transplantation: Where do we stand? 80
Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis 78
Geotrichum capitatum Invasive Infection Early After Liver Transplant 78
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 77
Tips for portal vein thrombosis (pvt) in cirrhosis: Not only unblocking a pipe 76
Local prothrombotic state in portal venous system in cirrhosis 76
Acute Allograft Rejection After Liver Transplantation: Incidence, Risk Factors and Impact On Outcome 75
Management of Severe Bleeding in Liver Disease and Transplantation 75
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma 74
Antibiotic therapy for spontaneous bacterial peritonitis in acute-on-chronic liver failure: Handle with care 73
Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered 73
Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures 72
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 71
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 71
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data 71
Estimation of Liver Transplant Related Survival Benefit: The Devil Is in the Details 71
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective 70
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 70
Acute Cellular Rejection in Liver Transplanted Patients: Incidence, Risk Factors, and Impact on Outcome 69
Evaluation of Physician Agreement For Defining "clinical Suspicion of Rejection" In Liver Transplantation 69
Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy. 68
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 68
Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease 68
Fibrosis Progression in Non Responders to Antiviral Treatment (AT) in HCV Recurrence Following Liver Transplantation (LT): An Italian Multicenter Retrospective Study 66
Screening and treatment of portal vein thrombosis in cirrhosis 66
Transjugular intrahepatic portosystemic shunt in non-cirrhotic portal hypertension related to cystic fibrosis in a lung transplant patient 66
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 65
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension 64
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 64
A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis 63
Management of portal hypertension severe complications 63
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 60
Hypnotic Hallucination of Body Heating Modifies Splanchnic Circulation: Haemodynamic and Ultrasonographic Pilot Study in Normal Volunteers 59
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 59
Managment of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Trasplantation: a Systematic Review 58
The concept of Quality of Life in organ transplantation 57
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 57
Effect of low molecular weight heparin (LMWH) on thrombin generation in cirrhotic patients 55
Drug induced liver injury: from pathogenesis to liver transplantation 55
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 55
Veno occlusive disease: up-date on clinical menagement. 54
Increased thrombin generation in liver transplant recipients: does immunosuppressive therapy play a role? 54
Management of Portal Vein (pvt) and Splacnic Veins Thrombosis (svt) In Liver Transplantation Candidates 53
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 52
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 47
Evaluation of intestinal barrier function and histologic aspects "in vivo" and its normalization after beta-blocker treatment in patients with cirrhosis and portal hypertension 46
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 46
Algorithm for the management of portal vein thrombosis: a prospective study in patients with liver cirrhosis 45
Algorithm For the Management of Portal Vein Thrombosis (pvt) In Patients With Cirrhosis: A Prospective Case-control Study 44
Impact of Antiviral Therapy on Fibrosis Progression Due to HCV Recurrence after Liver Transplantation: Results from the AISF RECOLT-C Study Group 43
Machine learning in liver transplantation: a tool for some unsolved questions? 43
Totale 8.354
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.862
article - articoli 41.259
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 246
Totale 84.367
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020860 0 0 0 0 0 0 168 186 183 148 133 42
2020/20211.277 71 76 110 79 63 53 58 106 162 158 137 204
2021/20221.740 61 177 218 106 72 185 99 157 67 86 154 358
2022/20231.269 238 120 37 130 226 146 19 97 152 11 84 9
2023/2024870 41 146 100 76 79 103 72 30 28 53 69 73
2024/20251.003 2 241 156 123 379 92 10 0 0 0 0 0
Totale 9.367